Starboard says Kenvue's skin health segment weighing on performance
Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...
Kenvue's Double Catalysts: Starboard Stake and Dividend Announcement
Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol, Band-Aid, Zirtec, Listerine, ...
Kenvue needs to fix its skin, health & beauty segments, Starboard's Jeff Smith says (update)
Financial writer analyzes activist hedge fund CEO's call for Kenvue to revamp skincare, health, and beauty segments for ...
Starboard says Kenvue's skin health segment is weighing on performance
By Svea Herbst-Bayliss (Reuters) -Hedge fund Starboard Value called consumer products company Kenvue a bargain and said its ...
Starboard Takes Stake in Consumer Products Maker Kenvue, Sources Say
(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...
Activist Starboard Holds Kenvue Stake and Seeks Changes, WSJ Reports
Shares of consumer-products company Kenvue Inc. rose the most in two months after the Wall Street Journal reported that ...
Tylenol Maker Kenvue Stock Surges on Report Starboard Takes 'Sizable Stake'
Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.
Activist Starboard Value Takes Stake in Tylenol-Maker Kenvue
Starboard wants Kenvue, which was spun out of Johnson & Johnson last year and has a market value of over $40 billion, to make ...
Activist Starboard could push for Kenvue to sell some/all of its SHB business - analyst
Financial writer highlights activist investor Starboard Value's push for Kenvue (KVUE) to divest its challenged skin, ...
BioSpace2d
Activist Investor Starboard Takes Aim at J&J Spinoff Kenvue on Heels of $1B Stake in Pfizer
Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...
FiercePharma3d
Activist investor Starboard sets its sights on J&J spinout Kenvue: WSJ
Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...
Starboard Focused on Kenvue's Struggling Unit
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...